Cover Image
Market Research Report

Specialty Pharmaceuticals Market, by Country(US, UK, France, Germany, Italy, Spain, Japan, South Korea), Application, Company, Global Analysis

Published by Renub Research Product code 910087
Published Content info 302 Pages
Delivery time: 1-2 business days
Price
Back to Top
Specialty Pharmaceuticals Market, by Country(US, UK, France, Germany, Italy, Spain, Japan, South Korea), Application, Company, Global Analysis
Published: September 1, 2019 Content info: 302 Pages
Description

Specialty pharmaceuticals are regarded to be a drug molecule that helps in the treatment of particular genetic conditions that have no therapeutic action on the market. Specialty Pharmaceuticals considered to be more targeted drugs than traditional drugs and are also less toxic. Specialty pharmaceutical consists of products like blood-derived, biopharmaceuticals, and complex molecules. Specialty pharmaceuticals are high cost and complex drugs; the average price per patient per year for specialty medical therapy is about $35,000 to $75,000. Specialty pharmaceutical is used to treat rare diseases such as Hepatitis C, Cancer, Rheumatoid Arthritis, AIDS (Acquired Immunodeficiency Virus Syndrome), Crohn's disease, etc. Global Specialty Pharmaceuticals Market is expected to be USD 568 Billion by 2026.

Specialty pharmacy is multiplying and becoming a significant factor for health systems and producers across the United States. The FDA approved 21 new molecular entities in the second half of 2018. Out of these products, 12 (57%) are regarded pharmaceutical specialties based on variables such as indication and designed use population, administrative and tracking considerations, price and/or restricted delivery procedures. In the last five years, United States spending on specialty drugs has almost doubled.

Renub Research report titled "Specialty Pharmaceuticals Market, by Country (United States, United Kingdom, France, Germany, Italy, Spain, Japan, South Korea), Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis, Others), Company (Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals) Global Analysis" provides a complete analysis of Global Specialty Pharmaceutical Market.

Oncology, Autoimmune, and Immunology are among the most significant application of global specialty pharmaceutical market

The report studies the market of the following application segments: Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis and Others. Due to the rising cases of oncology globally, Oncology is the leading application segment in this market place.

Specialty Pharmaceutical Market Share is expected to cross half of the global pharmaceutical market

Global pharmaceutical market is segmented by two types: traditional pharmaceutical and specialty pharmaceutical. At present, traditional pharmaceutical is in the dominating position across the globe, but due to increasing demands of specialty pharmaceutical products, it is anticipated that specialty pharmaceuticals will lead during the forecast period.

Company Analysis

Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals are some of the companies that deal efficiently in the specialty pharmaceuticals business. These companies have been studied thoroughly in the report.

Global Specialty Pharmaceutical Market - By Country

  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain
  • Japan
  • South Korea

Global Specialty Pharmaceutical Market - By Application

  • Oncology
  • Autoimmune
  • Immunology
  • HIV
  • Multiple Sclerosis
  • Viral Hepatitis
  • Blood Coagulation
  • Respiratory
  • Osteoporosis and
  • All Others

Global Pharmaceutical Market - By Segments

  • Global
  • Traditional
  • Specialty

Global Specialty Pharmaceutical Market - Company Covered

  • Teva Pharmaceutical
  • CVS Health
  • Endo International
  • UnitedHealth Group Incorporated
  • Recordati Pharmaceuticals
Table of Contents

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Global Specialty Pharmaceuticals

  • 4.1. Market
  • 4.2. Specialty Drug Pipeline

5. Market Share - Specialty Pharmaceutical Analysis

  • 5.1. By Country
  • 5.2. By Pharmaceutical Industry
  • 5.3. By Application

6. Global Pharmaceuticals Analysis

  • 6.1. Total Market
  • 6.2. Traditional Pharmaceutical Market

7. Country - Specialty Pharmaceutical

  • 7.1. United States
    • 7.1.1. Market
    • 7.1.2. Specialty Drug Pipeline
  • 7.2. Top 5 European Country
    • 7.2.1. Market
    • 7.2.2. Specialty Drug Pipeline
  • 7.3. United Kingdom
    • 7.3.1. Market
    • 7.3.2. Specialty Drug Pipeline
  • 7.4. France
    • 7.4.1. Market
    • 7.4.2. Specialty Drug Pipeline
  • 7.5. Germany
    • 7.5.1. Market
    • 7.5.2. Specialty Drug Pipeline
  • 7.6. Italy
    • 7.6.1. Market
    • 7.6.2. Specialty Drug Pipeline
  • 7.7. Spain
    • 7.7.1. Market
    • 7.7.2. Specialty Drug Pipeline
  • 7.8. Japan
    • 7.8.1. Market
    • 7.8.2. Specialty Drug Pipeline
  • 7.9. South Korea
    • 7.9.1. Market
    • 7.9.2. Specialty Drug Pipeline

8. Application - Specialty Pharmaceutical Market

  • 8.1. Oncology
  • 8.2. Autoimmune
  • 8.3. Immunology
  • 8.4. HIV
  • 8.5. Multiple Sclerosis (MS)
  • 8.6. Viral Hepatitis
  • 8.7. Blood Coagulation
  • 8.8. Respiratory
  • 8.9. Osteoporosis
  • 8.10. All Others

9. Market Dynamics

  • 9.1. Growth Drivers
    • 9.1.1. Improving Life Expectancy
    • 9.1.2. Surge in Spending on Medicines
    • 9.1.3. Prevalence of Chronic Disease
  • 9.2. Key Challenges
    • 9.2.1. Abandonment Rates for Specialty Medicines & High R&D Costs

10. Trend and Opportunities

  • 10.1. Trends
    • 10.1.1. Increased Spending on Specialty Pharmacy
    • 10.1.2. A Generic Wave of Specialty Drugs
    • 10.1.3. An Ever-expanding Pipeline of Products
    • 10.1.4. Targeted Therapies to Emerge
    • 10.1.5. Healthcare Reforms to Take Control
    • 10.1.6. Growth of Co-Pay Programs
    • 10.1.7. Medication Therapy Management (MTM) will Advance
    • 10.1.8. Specialty Prescribing to Rise
    • 10.1.9. Real-Time Pharmacy Benefit
  • 10.2. Opportunities
    • 10.2.1. Leverage the Changing Face of Specialty Pharmacy Industry with Flat world Solutions

11. Specialty Pharmacy Mergers and Acquisitions

12. Company Analysis

  • 12.1. Teva Pharmaceutical Industries Ltd
    • 12.1.1. Overview
    • 12.1.2. Recent Developments
    • 12.1.3. Revenue
  • 12.2. CVS Health
    • 12.2.1. Overview
    • 12.2.2. Recent Developments
    • 12.2.3. Revenue
  • 12.3. Endo International Specialty Products
    • 12.3.1. Overview
    • 12.3.2. Recent Developments
    • 12.3.3. Revenue
  • 12.4. UnitedHealth Group Incorporated
    • 12.4.1. Overview
    • 12.4.2. Recent Developments
    • 12.4.3. Revenue
  • 12.5. Recordati Pharmaceuticals Ltd
    • 12.5.1. Overview
    • 12.5.2. Recent Developments
    • 12.5.3. Revenue

13. Conclusion

List of Figures:

  • Figure 01: Global - Specialty Market (Million US$), 2015 - 2018
  • Figure 02: Global - Forecast For Specialty Market (Million US$), 2019 - 2026
  • Figure 03: Global - Pharmaceutical Market Share By Segment (Percent), 2015 - 2018
  • Figure 04: Global - Forecast for Pharmaceutical Market Share By Segment (Percent), 2019 - 2026
  • Figure 05: Global - Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 06: Global - Pharmaceutical Forecast for market (Million US$), 2019 - 2026
  • Figure 07: Global - Traditional Pharmaceutical Market (Million US$), 2015 - 2018
  • Figure 08: Global - Forecast For Traditional Pharmaceutical Market (Million US$), 2019 - 2026
  • Figure 09: United States - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 10: United States - Forecast For Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 11: Top 5 European Countries - Specialty Pharmaceutical market (Billion US$) 2015 - 2018
  • Figure 12: Top 5 European Countries - Forecast for Specialty Pharmaceutical market (Billion US$) 2019 - 2026
  • Figure 13: United Kingdom - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 14: United Kingdom - Forecast for Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 15: France - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 16: France - Forecast For Specialty Pharmaceutical market (Million US$), ) 2019 - 2026
  • Figure 17: Germany - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 18: Germany - Forecast For Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 19: Italy - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 20: Italy - Forecast For Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 21: Spain - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 22: Spain - Forecast For Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 23: Japan - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 24: Japan - Forecast For Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 25: South Korea - Specialty Pharmaceutical market (Million US$), 2015 - 2018
  • Figure 26: South Korea - Forecast For Specialty Pharmaceutical market (Million US$), 2019 - 2026
  • Figure 27: By Application - Oncology Market (Million US$), 2015 - 2018
  • Figure 28: Forecast For by Application Oncology Market (Million US$), 2019 - 2026
  • Figure 29: Application - Autoimmune Market (Million US$), 2015 - 2018
  • Figure 30: Application - Forecast for Autoimmune Market (Million US$), 2019 - 2026
  • Figure 31: Application - Immunology Market (Million US$), 2015 - 2018
  • Figure 32: Application - Forecast for Immunology Market (Million US$), 2019 - 2026
  • Figure 33: Application - Human Immunodeficiency Virus Market (Million US$), 2015 - 2018
  • Figure 34: Application - Forecast for Human Immunodeficiency Virus Market (Million US$), 2019 - 2026
  • Figure 35: By Application - Multiple Sclerosis (MS) Market (Million US$), 2015 - 2018
  • Figure 36: Forecast For by Application - Multiple Sclerosis (MS) Market (Million US$), 2019 - 2026
  • Figure 37: Application - Viral Hepatitis Market (Million US$), 2015 - 2018
  • Figure 38: Application - Forecast for Viral Hepatitis Market (Million US$), 2019 - 2026
  • Figure 39: Application - Blood Coagulation Market (Million US$), 2015 - 2018
  • Figure 40: Application - Forecast for Blood Coagulation Market (Million US$), 2019 - 2026
  • Figure 41: Application - Respiratory Market (Million US$), 2015 - 2018
  • Figure 42: Application - Forecast for Respiratory Market (Million US$), 2019 - 2026
  • Figure 43: Application - Osteoporosis Market (Million US$), 2015 - 2018
  • Figure 44: Application - Forecast for Osteoporosis Market (Million US$), 2019 - 2026
  • Figure 45: Application - All Others Market (Million US$), 2015 - 2018
  • Figure 46: Application - Forecast for All Others Market (Million US$), 2019 - 2026
  • Figure 47: Percentage of Global R&D Spending - by Pharma Companies
  • Figure 48: Teva Pharmaceutical Industries Ltd - Revenue (Million US$), 2014 - 2018
  • Figure 49: Teva Pharmaceutical Industries Ltd - Forecast For Revenue (Million US$), 2019 - 2026
  • Figure 50: CVS Health Revenue Market (Million US$), 2014 - 2018
  • Figure 51: Forecast For CVS Health Revenue Market (Million US$), 2019 - 2026
  • Figure 52: Endo International Specialty Products - Revenue (Million US$), 2014 - 2018
  • Figure 53: Endo International Specialty Products - Forecast For Revenue (Million US$), 2019 - 2026
  • Figure 54: UnitedHealth Group Incorporated - Revenue (Million US$), 2014 - 2018
  • Figure 55: UnitedHealth Group Incorporated - Forecast For Revenue (Million US$), 2019 - 2026
  • Figure 56: Recordati Pharmaceuticals Ltd - Revenue (Million US$), 2014 - 2018
  • Figure 57: Recordati Pharmaceuticals Ltd - Forecast For Revenue (Million US$), 2019 - 2026

List of Tables:

  • Figure 01: Global Specialty Drug Pipeline
  • Figure 02: Global - Specialty Pharmaceutical Market Share By Country (Percent), 2015 - 2018
  • Figure 03: Global - Forecast For Specialty Pharmaceutical Market Share By Country (Percent), 2019 - 2026
  • Figure 04: Global - Specialty Pharmaceutical Market Share By Application (Percent), 2015 - 2018
  • Figure 05: Global - Forecast for Specialty Pharmaceutical Market Share By Application (Percent), 2019 - 2026
  • Figure 06: United States - Companies Specialty Drug/R&D Pipeline
  • Figure 07: Shire Specialty Drug Pipeline
  • Figure 08: Meldex international Clinical Trial
  • Figure 09: Therapeutics: focus on the Italian pipeline
  • Figure 10: Orphan Drugs and Advanced Therapies
  • Figure 11: Bioneer Corporation - Research & Development Pipeline
  • Figure 12: CORESTEM Inc - Research & Development Pipeline of
  • Figure 13: Crystal Genomics, Inc - Research & Development Pipeline
  • Figure 14: Genexine - Research & Development Pipeline
  • Figure 15: ViroMed Co. - Representative Product - Biologics (Clinical Trial)
  • Figure 16: Bcworld Pharm. Co., Ltd. - Main Products
  • Figure 17: Bcworld Pharm. Co., Ltd - R&D Pipeline
Back to Top